Supporting oncology professionals through education

The content on this site is intended for healthcare professionals only

News [5463]

AACR 2015: Pembrolizumab safe, with signs of clinical benefit, for patients with malignant pleural mesothelioma

AACR 2015: Pembrolizumab safe, with signs of clinical benefit, for patients with malignant pleural mesothelioma

Investigational non-small cell lung cancer drug, AZD9291, shows significant delay in disease progression

Investigational non-small cell lung cancer drug, AZD9291, shows significant delay in disease progression

Active Pin1 is a target for all-trans retinoic acid in leukaemia and breast cancer

Active Pin1 is a target for all-trans retinoic acid in leukaemia and breast cancer

New assay helps determine lymphoma subtypes simply, quickly, and inexpensively

New assay helps determine lymphoma subtypes simply, quickly, and inexpensively

Body's cancer defences hijacked to make pancreatic and lung cancers more aggressive

Body's cancer defences hijacked to make pancreatic and lung cancers more aggressive

New insights into blood vessel formation in cancer

New insights into blood vessel formation in cancer

Scientists drill down to genetic root of prostate tumour development

Scientists drill down to genetic root of prostate tumour development

Scientists trace genomic evolution of high-risk leukaemia

Scientists trace genomic evolution of high-risk leukaemia

Researchers effectively and safely overcome radiation resistance in leukaemia with an engineered precision medicine

Researchers effectively and safely overcome radiation resistance in leukaemia with an engineered precision medicine

Two trials show efficacy for enzalutamide in prostate cancer

Two trials show efficacy for enzalutamide in prostate cancer

More from ecancer